New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C ...

In this work, a complex in vivo model of tumors accompanied by surgical wound infection was applied. Bacteriophages modified with anticancer YIGSR peptides acted as the active agents. Evaluation ...

Now, scientists at ETH Zurich, in collaboration with Balgrist University Hospital, have created a fast and promising new test ...

Clostridioides difficile infection is a major healthcare-associated infection, causing significant morbidity and mortality, ...

This important study analyzes the effect of heat treatment on phage-bacterial interactions and convincingly shows that prior heat exposure alters the bacterial cell envelope, enhancing persistence and ...

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat ...

Returning to Boston this February, the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Uniting 90+ Chief Executive Officers, Vice Presidents ...